{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:33:14Z","timestamp":1793813594149,"version":"4.6.1"},"reference-count":89,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","license":[{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"HwaMei Reasearch Foundation of Ningbo No.2 Hospital","award":["2022HMKY48"],"award-info":[{"award-number":["2022HMKY48"]}]},{"name":"HwaMei Reasearch Foundation of Ningbo No.2 Hospital","award":["2023HMZD07"],"award-info":[{"award-number":["2023HMZD07"]}]},{"name":"Medical Scientific Reasearch Foundation of Zhejiang Province","award":["2023RC081"],"award-info":[{"award-number":["2023RC081"]}]},{"name":"Zhu Xiu Shan Talent Project of Ningbo No.2 Hospital","award":["2023HMJQ25"],"award-info":[{"award-number":["2023HMJQ25"]}]},{"name":"Ningbo Health Youth Technical Backbone Talent Development Program","award":["2024RC-QN-02"],"award-info":[{"award-number":["2024RC-QN-02"]}]},{"name":"Project of NINGBO Leading Medical & Health Discipline","award":["2022-F17"],"award-info":[{"award-number":["2022-F17"]}]},{"name":"Ningbo Top Medical and Health Research Program","award":["2023030615"],"award-info":[{"award-number":["2023030615"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11,8]]},"abstract":"<jats:p>This study aims to rigorously explore the potential causal relationships among gut microbiota (GM), immune cells, and melanoma skin cancer among participants from Europe, where this disease exhibits significant prevalence and profound societal impact. Using the genome-wide association analysis database, a double-sample Mendelian randomization (MR) analysis was drawn upon to investigate GM, immune cells, and melanoma skin cancer. The inverse variance weighted approach was applied to estimate the causal connections among these variables. A two-step MR analysis was employed to quantitatively gauge the impact of immune cells mediated GM on melanoma skin cancer. To address potential sources of bias, such as pleiotropy and heterogeneity, multiple analytical techniques were integrated. The MR analysis pinpointed 6 GM taxa related to either an augmented or declined risk of late-stage melanoma skin cancer. In the same vein, 32 immune cell phenotypes were noticed as correlates with modified risk of melanoma skin cancer. Our study also implies that the probable association between GM and melanoma could be facilitated by 5 immune cell phenotypes. The findings of our study underline certain GM taxa and immune cells as potential influencers on the onset and development of melanoma skin cancer. Importantly, our results spotlight 5 immune cell phenotypes as potential agents mediating this association.<\/jats:p>","DOI":"10.1097\/md.0000000000040432","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T15:00:45Z","timestamp":1731337245000},"page":"e40432","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["A two-step, two-sample Mendelian randomization analysis investigating the interplay between gut microbiota, immune cells, and melanoma skin cancer"],"prefix":"10.1097","volume":"103","author":[{"given":"Jiaqi","family":"Lou","sequence":"first","affiliation":[{"name":"Burn Department, Ningbo No. 2 Hospital, Ningbo, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Section of Medical Psychology, Faculty of Medicine, University of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Zhu","sequence":"additional","affiliation":[{"name":"Health Science Center, Ningbo University, Ningbo, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youfen","family":"Fan","sequence":"additional","affiliation":[{"name":"Burn Department, Ningbo No. 2 Hospital, Ningbo, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiliang","family":"Li","sequence":"additional","affiliation":[{"name":"Burn Department, Ningbo No. 2 Hospital, Ningbo, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoying","family":"Jin","sequence":"additional","affiliation":[{"name":"Burn Department, Ningbo No. 2 Hospital, Ningbo, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyong","family":"Cui","sequence":"additional","affiliation":[{"name":"Burn Department, Ningbo No. 2 Hospital, Ningbo, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neng","family":"Huang","sequence":"additional","affiliation":[{"name":"Burn Department, Ningbo No. 2 Hospital, Ningbo, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4241-3791","authenticated-orcid":false,"given":"Xin","family":"Le","sequence":"additional","affiliation":[{"name":"Burn Department, Ningbo No. 2 Hospital, Ningbo, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.2022.24888","article-title":"What is melanoma?","volume":"329","author":"Wang","year":"2023","journal-title":"JAMA"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","article-title":"Global burden of cutaneous melanoma in 2020 and projections to 2040.","volume":"158","author":"Arnold","year":"2022","journal-title":"JAMA Dermatol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1007\/s12094-020-02318-6","article-title":"Malignancies after renal transplantation: experience of a Mexican referral center.","volume":"22","author":"Leon-Rodriguez","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/MCO.0000000000001009","article-title":"Nourishing the gut: the impact of diet on host-gut microbiota interaction.","volume":"27","author":"Masi","year":"2024","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"e202302480","DOI":"10.26508\/lsa.202302480","article-title":"Systemic metabolic depletion of gut microbiome undermines responsiveness to melanoma immunotherapy.","volume":"7","author":"Zakharevich","year":"2024","journal-title":"Life Sci Alliance"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41577-023-00951-0","article-title":"Role of the microbiota in response to and recovery from cancer therapy.","volume":"24","author":"Blake","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1158\/2159-8290.CD-24-0066","article-title":"Randomized placebo-controlled, biomarker-stratified phase Ib microbiome modulation in melanoma: impact of antibiotic preconditioning on microbiome and immunity.","volume":"14","author":"Glitza","year":"2024","journal-title":"Cancer Discov"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41591-024-02803-3","article-title":"Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma.","volume":"30","author":"Bj\u00f6rk","year":"2024","journal-title":"Nat Med"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.hoc.2024.04.005","article-title":"Skin cancer precursors: from cancer genomics to early diagnosis.","volume":"38","author":"Taylor","year":"2024","journal-title":"Hematol Oncol Clin North Am"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1080\/1744666X.2024.2326626","article-title":"Tumor associated macrophages as key contributors and targets in current and future therapies for melanoma.","volume":"20","author":"Habib","year":"2024","journal-title":"Expert Rev Clin Immunol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1435187","DOI":"10.3389\/fimmu.2024.1435187","article-title":"Advancing immunotherapy for melanoma: the critical role of single-cell analysis in identifying predictive biomarkers.","volume":"15","author":"He","year":"2024","journal-title":"Front Immunol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.3390\/microorganisms11102386","article-title":"Role of the microbiota in skin neoplasms: new therapeutic horizons.","volume":"11","author":"Savoia","year":"2023","journal-title":"Microorganisms"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ccell.2023.12.003","article-title":"Melanoma and microbiota: current understanding and future directions.","volume":"42","author":"Routy","year":"2024","journal-title":"Cancer Cell"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"104403","DOI":"10.1016\/j.critrevonc.2024.104403","article-title":"A viable remedy for overcoming resistance to anti-PD-1 immunotherapy: fecal microbiota transplantation.","volume":"200","author":"Meng","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1080\/14737140.2023.2262765","article-title":"The long and winding road of faecal microbiota transplants to targeted intervention for improvement of immune checkpoint inhibition therapy.","volume":"23","author":"Verhoef","year":"2023","journal-title":"Expert Rev Anticancer Ther"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1433299","DOI":"10.3389\/fimmu.2024.1433299","article-title":"Causal association between immune cells and lung cancer risk: a two-sample bidirectional Mendelian randomization analysis.","volume":"15","author":"Xu","year":"2024","journal-title":"Front Immunol"},{"key":"R17-20250504","article-title":"Causal links between immune cells and asthma: insights from a Mendelian randomization analysis","author":"Xu","journal-title":"J Asthma"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41588-019-0350-x","article-title":"Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases.","volume":"51","author":"Sanna","year":"2019","journal-title":"Nat Genet"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/ng.3359","article-title":"Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations.","volume":"47","author":"Liu","year":"2015","journal-title":"Nat Genet"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","article-title":"Complex genetic signatures in immune cells underlie autoimmunity and inform therapy.","volume":"52","author":"Orr\u00f9","year":"2020","journal-title":"Nat Genet"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/ng.3368","article-title":"Genome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood inflammatory markers.","volume":"47","author":"Sidore","year":"2015","journal-title":"Nat Genet"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/jamaoncol.2017.2316","article-title":"Association between telomere length and risk of cancer and non-neoplastic diseases: a Mendelian randomization study.","volume":"3","author":"Haycock","year":"2017","journal-title":"JAMA Oncol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1186\/s12885-021-09067-x","article-title":"Blood pressure and risk of cancer: a Mendelian randomization study.","volume":"21","author":"Chan","year":"2021","journal-title":"BMC Cancer"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-4939-7868-7_4","article-title":"Genome-wide association studies.","volume":"1793","author":"Dehghan","year":"2018","journal-title":"Methods Mol Biol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/sim.6835","article-title":"Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods.","volume":"35","author":"Burgess","year":"2016","journal-title":"Stat Med"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/ije\/dyu005","article-title":"Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome.","volume":"43","author":"Burgess","year":"2014","journal-title":"Int J Epidemiol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"e1007081","DOI":"10.1371\/journal.pgen.1007081","article-title":"Orienting the causal relationship between imprecisely measured traits using GWAS summary data.","volume":"13","author":"Hemani","year":"2017","journal-title":"PLoS Genet"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies.","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies.","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"2319712","DOI":"10.1080\/0886022X.2024.2319712","article-title":"Recent advances in the application of Mendelian randomization to chronic kidney disease.","volume":"46","author":"Wen","year":"2024","journal-title":"Ren Fail"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"1230125","DOI":"10.3389\/fmicb.2023.1230125","article-title":"Association between gut microbiota and sensorineural hearing loss: a Mendelian randomization study.","volume":"14","author":"Yin","year":"2023","journal-title":"Front Microbiol"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"1382777","DOI":"10.3389\/fendo.2024.1382777","article-title":"Mendelian randomization study and mediation analysis about the relation of inflammatory bowel disease and diabetic retinopathy: the further exploration of gut-retina axis.","volume":"15","author":"Lin","year":"2024","journal-title":"Front Endocrinol"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"2291885","DOI":"10.1080\/19382014.2023.2291885","article-title":"The causal relationship between bacterial pneumonia and diabetes: a two-sample mendelian randomization study.","volume":"16","author":"Pan","year":"2024","journal-title":"Islets"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s11912-024-01556-z","article-title":"Management of localized Melanoma in the anti-PD-1 era.","volume":"26","author":"Novis","year":"2024","journal-title":"Curr Oncol Rep"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41571-023-00803-9","article-title":"Towards modulating the gut microbiota to enhance the efficacy of immune-checkpoint inhibitors.","volume":"20","author":"Simpson","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.3390\/cancers16101806","article-title":"Gut microbiota are a novel source of biomarkers for immunotherapy in non-small-cell lung cancer (NSCLC).","volume":"16","author":"Del Giudice","year":"2024","journal-title":"Cancers"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1186\/s12885-024-12843-0","article-title":"Comprehensive pan-cancer analysis reveals EPHB2 is a novel predictive biomarker for prognosis and immunotherapy response.","volume":"24","author":"Xu","year":"2024","journal-title":"BMC Cancer"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"1155182","DOI":"10.3389\/fimmu.2023.1155182","article-title":"Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.","volume":"14","author":"Xu","year":"2023","journal-title":"Front Immunol"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"2268982","DOI":"10.1080\/21645515.2023.2268982","article-title":"Gut microbiota and immunotherapy of renal cell carcinoma.","volume":"19","author":"Bibb\u00f2","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1007\/s00204-024-03770-x","article-title":"Targeting gut microbiota for immunotherapy of diseases.","volume":"98","author":"Yu","year":"2024","journal-title":"Arch Toxicol"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"11611","DOI":"10.3390\/ijms241411611","article-title":"Gut microbiota, metabolome, and body composition signatures of response to therapy in patients with advanced melanoma.","volume":"24","author":"Vandoni","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"887383","DOI":"10.3389\/fonc.2022.887383","article-title":"The gut microbiota modulates responses to anti-PD-1 and chemotherapy combination therapy and related adverse events in patients with advanced solid tumors.","volume":"12","author":"Wu","year":"2022","journal-title":"Front Oncol"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"1339621","DOI":"10.3389\/fmicb.2024.1339621","article-title":"Causal associations between gut microbiota and cutaneous melanoma: a Mendelian randomization study.","volume":"15","author":"Bao","year":"2024","journal-title":"Front Microbiol"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients.","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13073-019-0672-4","article-title":"Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients.","volume":"11","author":"Peters","year":"2019","journal-title":"Genome Med"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.aao3290","article-title":"The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients.","volume":"359","author":"Matson","year":"2018","journal-title":"Science"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"101736","DOI":"10.1016\/j.jormas.2023.101736","article-title":"Association of gut microbiome and oral cavity cancer: a two sample Mendelian randomization and case-control study.","volume":"125","author":"Liu","year":"2023","journal-title":"J Stomatol Oral Maxillofac Surg"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"1412035","DOI":"10.3389\/fcimb.2024.1412035","article-title":"Refining the relationship between gut microbiota and common hematologic malignancies: insights from a bidirectional Mendelian randomization study.","volume":"14","author":"Chen","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00253-023-12845-1","article-title":"Distinct alterations of gut microbiota between viral- and non-viral-related hepatocellular carcinoma.","volume":"108","author":"Jinato","year":"2024","journal-title":"Appl Microbiol Biotechnol"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"12856","DOI":"10.3390\/ijms241612856","article-title":"Unique gut microbiome signatures among adult patients with moderate to severe atopic dermatitis in Southern Chinese.","volume":"24","author":"Wang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"100698","DOI":"10.1016\/j.bj.2024.100698","article-title":"Gut microbiota and clinical response to immune checkpoint inhibitor therapy in patients with advanced cancer.","volume":"47","author":"Chang","year":"2024","journal-title":"Biomed J"},{"key":"R53-20250504","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.3390\/cancers15133268","article-title":"Assessing the performance of a novel stool-based microbiome test that predicts response to first line immune checkpoint inhibitors in multiple cancer types.","volume":"15","author":"Robinson","year":"2023","journal-title":"Cancers"},{"key":"R54-20250504","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1158\/2326-6066.CIR-19-1014","article-title":"The gut microbiome is associated with clinical response to anti-PD-1\/PD-L1 immunotherapy in gastrointestinal cancer.","volume":"8","author":"Peng","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"R55-20250504","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.3390\/cancers14215369","article-title":"A clinical outcome of the anti-PD-1 therapy of melanoma in polish patients is mediated by population-specific gut microbiome composition.","volume":"14","author":"Pietrzak","year":"2022","journal-title":"Cancers"},{"key":"R56-20250504","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.semcancer.2019.08.002","article-title":"Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment.","volume":"59","author":"Marzagalli","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"R57-20250504","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1038\/s41467-023-39042-y","article-title":"B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma.","volume":"14","author":"Crescioli","year":"2023","journal-title":"Nat Commun"},{"key":"R58-20250504","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1186\/s12885-024-12603-0","article-title":"Causal association between skin cancer and immune cells: Mendelian randomization (MR) study.","volume":"24","author":"Yin","year":"2024","journal-title":"BMC Cancer"},{"key":"R59-20250504","article-title":"Evidence for a causal relationship between immune cells and cutaneous melanoma: a Mendelian randomization study","author":"Huang","journal-title":"Int J Dermatol"},{"key":"R60-20250504","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/pcmr.13031","article-title":"A B-cell or a key player? The different roles of B-cells and antibodies in melanoma.","volume":"35","author":"Rodgers","year":"2022","journal-title":"Pigment Cell Melanoma Res"},{"key":"R61-20250504","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41586-023-06231-0","article-title":"B-cell-specific checkpoint molecules that regulate anti-tumour immunity.","volume":"619","author":"Bod","year":"2023","journal-title":"Nature"},{"key":"R62-20250504","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00262-011-1071-x","article-title":"Prognostic impact of B-cell density in cutaneous melanoma.","volume":"60","author":"Lad\u00e1nyi","year":"2011","journal-title":"Cancer Immunol Immunother"},{"key":"R63-20250504","first-page":"12","article-title":"Identification of CD38 as a potential biomarker in skin cutaneous melanoma using bioinformatics analysis.","volume":"20","author":"Wang","year":"2020","journal-title":"Oncol Lett"},{"key":"R64-20250504","doi-asserted-by":"crossref","first-page":"31797","DOI":"10.18632\/oncotarget.25737","article-title":"Stromal CD38 regulates outgrowth of primary melanoma and generation of spontaneous metastasis.","volume":"9","author":"Ben Baruch","year":"2018","journal-title":"Oncotarget"},{"key":"R65-20250504","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1158\/2159-8290.CD-17-1033","article-title":"CD38-mediated immunosuppression as a mechanism of tumor cell escape from PD-1\/PD-L1 blockade.","volume":"8","author":"Chen","year":"2018","journal-title":"Cancer Discovery"},{"key":"R66-20250504","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/cei\/uxab005","article-title":"Innate stimulation of B cells ex vivo enhances antibody secretion and identifies tumour-reactive antibodies from cancer patients.","volume":"207","author":"Karagiannis","year":"2022","journal-title":"Clin Exp Immunol"},{"key":"R67-20250504","doi-asserted-by":"crossref","first-page":"1050528","DOI":"10.3389\/fimmu.2023.1050528","article-title":"B cell-activating factor (BAFF) from dendritic cells, monocytes and neutrophils is required for B cell maturation and autoantibody production in SLE-like autoimmune disease.","volume":"14","author":"Giordano","year":"2023","journal-title":"Front Immunol"},{"key":"R68-20250504","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s00432-021-03555-0","article-title":"Exploring the role of BAFF as biomarker in the detection of uveal melanoma metastases.","volume":"147","author":"Lin","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"R69-20250504","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/0008-5472.CAN-21-1171","article-title":"BAFF attenuates immunosuppressive monocytes in the melanoma tumor microenvironment.","volume":"82","author":"Liu","year":"2022","journal-title":"Cancer Res"},{"key":"R70-20250504","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3390\/cancers16081461","article-title":"Adjuvant PD-1 checkpoint inhibition in early cutaneous melanoma: immunological mode of action and the role of ultraviolet radiation.","volume":"16","author":"Brandlmaier","year":"2024","journal-title":"Cancers"},{"key":"R71-20250504","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s13046-024-03138-0","article-title":"Tumor-derived GLI1 promotes remodeling of the immune tumor microenvironment in melanoma.","volume":"43","author":"Giammona","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"R72-20250504","doi-asserted-by":"crossref","first-page":"104290","DOI":"10.1016\/j.pdpdt.2024.104290","article-title":"Photothermal therapy improves the efficacy of topical immunotherapy against melanoma.","volume":"49","author":"Shi","year":"2024","journal-title":"Photodiagn Photodyn Ther"},{"key":"R73-20250504","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3390\/biom10081087","article-title":"Significance of immunosuppressive cells as a target for immunotherapies in melanoma and non-melanoma skin cancers.","volume":"10","author":"Fujimura","year":"2020","journal-title":"Biomolecules"},{"key":"R74-20250504","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s41423-023-01013-0","article-title":"The chemokine monocyte chemoattractant protein-1\/CCL2 is a promoter of breast cancer metastasis.","volume":"20","author":"Yoshimura","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"R75-20250504","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.medj.2024.03.015","article-title":"Myeloid-T cell interplay and cell state transitions associated with checkpoint inhibitor response in melanoma.","volume":"5","author":"Schlenker","year":"2024","journal-title":"Med"},{"key":"R76-20250504","doi-asserted-by":"crossref","first-page":"1285895","DOI":"10.3389\/fimmu.2023.1285895","article-title":"HLA-DR expression in melanoma: from misleading therapeutic target to potential immunotherapy biomarker.","volume":"14","author":"Amrane","year":"2024","journal-title":"Front Immunol"},{"key":"R77-20250504","first-page":"116","article-title":"Tumor metastasis biopsy as a surrogate marker of response to melanoma immunotherapy.","volume":"31","author":"Zehntner","year":"1999","journal-title":"Pathology (Phila)"},{"key":"R78-20250504","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1158\/0008-5472.CAN-14-2956","article-title":"Aberrant expression of MHC class II in melanoma attracts inflammatory tumor-specific CD4+ T-cells, which dampen CD8+ T-cell antitumor reactivity.","volume":"75","author":"Donia","year":"2015","journal-title":"Cancer Res"},{"key":"R79-20250504","doi-asserted-by":"crossref","first-page":"6564","DOI":"10.1038\/sj.onc.1206960","article-title":"Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach?","volume":"22","author":"Altomonte","year":"2003","journal-title":"Oncogene"},{"key":"R80-20250504","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00105-022-05076-4","article-title":"Tumorinfiltrierende T-Zellen und nat\u00fcrliche Killerzellen im Melanom [Tumor-infiltrating natural killer and T cells in melanoma].","volume":"73","author":"Tietze","year":"2022","journal-title":"Dermatologie (Heidelb)"},{"key":"R81-20250504","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.3390\/cancers13174263","article-title":"Inhibitory receptors and immune checkpoints regulating natural killer cell responses to cancer.","volume":"13","author":"Buckle","year":"2021","journal-title":"Cancers"},{"key":"R82-20250504","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1172\/JCI125916","article-title":"Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming.","volume":"129","author":"Merino","year":"2019","journal-title":"J Clin Invest"},{"key":"R83-20250504","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.3390\/cancers12123694","article-title":"Role of natural killer cells in uveal melanoma.","volume":"12","author":"Javed","year":"2020","journal-title":"Cancers"},{"key":"R84-20250504","doi-asserted-by":"crossref","first-page":"e12861","DOI":"10.1111\/sji.12861","article-title":"New avenues for melanoma immunotherapy: natural killer cells?","volume":"91","author":"Cristiani","year":"2020","journal-title":"Scand J Immunol"},{"key":"R85-20250504","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00262-022-03276-4","article-title":"PD-L1 antibody enhanced \u03b2-glucan antitumor effects via blockade of the immune checkpoints in a melanoma model.","volume":"72","author":"Hu","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"R86-20250504","doi-asserted-by":"crossref","first-page":"5911","DOI":"10.3390\/cancers14235911","article-title":"BG34-200 immunotherapy of advanced melanoma.","volume":"14","author":"Roche","year":"2022","journal-title":"Cancers"},{"key":"R87-20250504","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/DAD.0000000000000382","article-title":"Consumption of the epidermis: a suggested precursor of ulceration associated with increased proliferation of melanoma cells.","volume":"37","author":"B\u00f8nnelykke-Behrndtz","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"R88-20250504","article-title":"A guide to understanding Mendelian randomization studies","author":"Nguyen","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R89-20250504","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s11427-023-2522-8","article-title":"An overview of detecting gene-trait associations by integrating GWAS summary statistics and eQTLs.","volume":"67","author":"Zhang","year":"2024","journal-title":"Sci China Life Sci"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040432","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T21:01:53Z","timestamp":1746306113000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":89,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040432","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,8]]}}}